|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | P53 overexpression as an indicator of overall survival and response to treatment in osteosarcomas显示文摘 | Papai Z Feja CN Hanna EN | 1997 | Pathol Oncol Res1997，3，1： | 1 |
| 2 | Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory ad- vanced soft tissue sarcoma:A phase II study from the European or- ganisation for research and treatment of cancer - soft tissue and bone sarcoma group ( EORTC study 62043 ) 显示文摘 | Sleijfer S Ray Coquard I Papai Z | 2009 | J Clin Oncol2009，27，19： | 1 |
| 3 | Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2) 显示文摘 | Pritchard KI Rolski J Papai Z | 2010 | Breast Cancer Res Treat2010，123，2： | 1 |
| 4 | Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043) 显示文摘 | Sleijfer S Ray-Coquard I Papai Z | 2009 | J Clin Oncol2009，27，19： | 1 |
| 5 | Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2) 显示文摘 | Pritchard KI Rolski J Papai Z | 2010 | Breast Cancer Cancer Res Treat2010，123，2： | 1 |
| 6 | Open-label,multicenter,randomizad,phase Ⅲ study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer显示文摘 | Eckordt JR von Pawel J Papai Z | 2006 | J Clin Oncol2006，24，13： | 1 |
| 7 | Pazopanib,a multikinase angiogenesis inhibitor,in patients with relapsed or refractory advanced soft tissue sarcoma:a phase Ⅱ study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043)显示文摘 | Sleijfer S Ray-Coquard I Papai Z | 2009 | J Clin Oncol2009，27，19： | 1 |
| 8 | Results of a phaseII study comparing three dosing regimens of fulvestrantin postmenopausal women with advanced breast cancer(FINDER2)显示文摘 | Pritchard KI Rolski J Papai Z | 2010 | Breast Cancer Res Treat2010，123，2： | 1 |
| 9 | Open-label,multicenter,randomized,phase Ⅲ study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapynaive patients with extensive-disease small-cell lung cancer显示文摘 | Eckardt JR von Pawel J Papai Z | 2006 | J Clin Oncol2006，24，13： | 1 |
| 10 | Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: A phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043) 显示文摘 | Sleijfer S ftay-Coquard I Papai Z | 2009 | J Clin Oncol2009，27，19： | 1 |
| 11 | Pazopanib,a multikinase angiogenesis inhibitor,in patients with relapsed or refractory advanced soft tissue sarcoma:a phase Ⅱ study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043)显示文摘 | Sleijfer S Ray-Coquard I Papai Z | 2009 | J Clin Oncol2009，27，： | 1 |
| 12 | Limb-saving surgery,survival,and prognostic factors for osteosarcoma:The Hungarian experience显示文摘 | SZENDROI M PAPAI Z KOOS R | | 0，，： | 1 |
| 13 | Limb-saving surgery, survival, and prognostic factors for osteosarcoma: the Hungarian experience 显示文摘 | Szendroi M Papai Z Koos R | 2000 | J Surg Oncol2000，73，2： | 1 |
| 14 | Companable activity with oral topotecan/cisplatin(TC) and Ⅳ etoposide/cisplatin(PE) as treatment of chemotherapy naive patients (pts)with extensive disease small cell lung cancer (ED-SCLC):Final results of a randomized phase Ⅲ trial(389)显示文摘 | PAWEL J MANIKHAS G PAPAI Z | 2005 | J Clin Oncol2005，126，10： | 1 |
| 15 | Phase III trial of two investiga-tional schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma:a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study显示文摘 | Lorigan P Verweij J Papai Z | 2007 | J Clin Oncol2007，25，21： | 1 |
| 16 | Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study显示文摘 | Lorigan P Verweij J Papai Z | 2007 | J Clin Oncol2007，25，21： | 1 |
| 17 | Open-label,multicenter,randomized,phaseⅢstudy comparing oraltopotecan/cisplatin versus etoposide/cisplatin as treat-ment for chemotherapy-naive patients with extensive-disease small-cell lung cancer显示文摘 | Eckardt JR von Pawel J Papai Z | 2006 | J Clin Oncol2006，24，13： | 1 |
| 18 | Open-label,multicenter,randomized,phase Ⅲ study comparing oral topotecan/cisplatin versus etopeside/cisplatin as treatment for chemotherapy-naive patients with extensive disease small cell lung cancer显示文摘 | Eckardt JR yon Pawel J Papai Z | | 0，，： | 1 |
| 19 | Results of a phase Ⅱ study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)显示文摘 | Pritchard K I Rolski J Papai Z | | 0，，02： | 1 |
| 20 | Pazopanib,a multikinase angiogenesis inhibitor,in patients with relapsed or refractory advanced soft tissue sarcoma:A phase Ⅱ study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC Study 62043)显示文摘 | Sleijfer S Ray-Coquard I Papai Z | 2009 | J Clin Oncol2009，27，19： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员